NO20060982L - Dispergerende formulering for et anti-inflammatorisk middel - Google Patents
Dispergerende formulering for et anti-inflammatorisk middelInfo
- Publication number
- NO20060982L NO20060982L NO20060982A NO20060982A NO20060982L NO 20060982 L NO20060982 L NO 20060982L NO 20060982 A NO20060982 A NO 20060982A NO 20060982 A NO20060982 A NO 20060982A NO 20060982 L NO20060982 L NO 20060982L
- Authority
- NO
- Norway
- Prior art keywords
- inflammatory agent
- dispersant formulation
- organ
- dispersant
- formulation
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 239000002270 dispersing agent Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 210000000056 organ Anatomy 0.000 abstract 2
- 210000000481 breast Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49212103P | 2003-07-31 | 2003-07-31 | |
| PCT/IB2004/002461 WO2005009436A1 (fr) | 2003-07-31 | 2004-07-19 | Formulation dispersable d'un agent anti-inflammatoire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060982L true NO20060982L (no) | 2006-05-02 |
Family
ID=34103027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060982A NO20060982L (no) | 2003-07-31 | 2006-02-28 | Dispergerende formulering for et anti-inflammatorisk middel |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1651210A1 (fr) |
| JP (1) | JP2007500691A (fr) |
| KR (1) | KR100780983B1 (fr) |
| CN (1) | CN1829510A (fr) |
| AU (1) | AU2004258745A1 (fr) |
| BR (1) | BRPI0412581A (fr) |
| CA (1) | CA2533101A1 (fr) |
| CO (1) | CO5650245A2 (fr) |
| IL (1) | IL172735A0 (fr) |
| MX (1) | MXPA06001288A (fr) |
| NO (1) | NO20060982L (fr) |
| RU (1) | RU2319508C2 (fr) |
| WO (1) | WO2005009436A1 (fr) |
| ZA (1) | ZA200600096B (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20081406A1 (es) * | 2006-12-20 | 2008-10-17 | Schering Plough Ltd | Composiciones farmaceuticas de flunixina |
| GB0711776D0 (en) * | 2007-06-18 | 2007-07-25 | Syngenta Participations Ag | Substituted aromatic heterocyclic compounds as fungicides |
| RU2392929C2 (ru) * | 2007-06-20 | 2010-06-27 | Общество С Ограниченной Ответственностью "Гамаветфарм" | Средство для стимуляции выброса стволовых кроветворных клеток в кровоток |
| UA111147C2 (uk) * | 2009-11-11 | 2016-04-11 | Байєр Б.В. | Способи та композиції для лікування або профілактики зовнішнього отиту |
| GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
| DK2366408T3 (da) * | 2010-03-01 | 2012-10-22 | Salvat Lab Sa | Vandige, klare opløsninger af fluocinolonacetonid til behandling af inflammation i øret |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| RU2486905C1 (ru) * | 2012-05-28 | 2013-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") | Средство для лечения мастита у животных |
| CN102784161A (zh) * | 2012-08-01 | 2012-11-21 | 张吉川 | 一种治疗急慢性中耳炎的特效滴耳液 |
| ES2763352T3 (es) * | 2013-01-14 | 2020-05-28 | Infirst Healthcare Ltd | Composiciones de solución sólida y uso en inflamación crónica |
| SG11201505243PA (en) * | 2013-02-04 | 2015-08-28 | Infirst Healthcare Ltd | Compositions and methods for treating chronic inflammation and inflammatory diseases |
| LV15071B (lv) * | 2015-07-14 | 2016-02-20 | Rīgas Stradiņa Universitāte | Kompozīcija subklīniska mastīta ārstēšanai govīm |
| CA2994702A1 (fr) | 2015-08-05 | 2017-02-09 | Children's Medical Center Corporation | Compositions ayant des amplificateurs de permeation pour l'administration de medicaments |
| US10561684B2 (en) | 2015-08-27 | 2020-02-18 | Min Bo SHIM | Pharmaceutical composition for preventing or treating sensorineural hearing loss or tinnitus including platelet-rich plasma and method using the same |
| KR101738815B1 (ko) * | 2015-08-27 | 2017-05-23 | 심민보 | 혈소판 풍부 혈장을 포함하는 감각신경성 난청 또는 이명을 예방 또는 치료하기 위한 약학적 조성물 및 이를 이용한 방법 |
| WO2019191547A1 (fr) * | 2018-03-29 | 2019-10-03 | Yale University | Nouveaux dérivés de pleuromutiline entièrement synthétiques et semi-synthétiques en tant que nouveaux antibiotiques et leur préparation |
| EP3829540A1 (fr) * | 2018-08-01 | 2021-06-09 | Novilla Pharmaceuticals, Inc. | Solvants eutectiques comprenant des agents pharmaceutiques, et leurs procédés de fabrication et d'utilisation |
| RU2749857C1 (ru) * | 2019-12-23 | 2021-06-17 | Псарева Нелли Александровна | Способ борьбы со средним и наружным отитом |
| RU2751697C1 (ru) * | 2020-09-09 | 2021-07-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Донской государственный аграрный университет" | Средство для лечения отитов наружного слухового прохода у собак |
| KR102461699B1 (ko) * | 2021-05-21 | 2022-11-03 | 현대약품 주식회사 | 벤지다민염산염을 포함하는 안정성이 개선된 가글액 |
| KR102785852B1 (ko) * | 2021-12-03 | 2025-03-26 | (주)인비보텍 | 난청 또는 이명의 예방 또는 치료용 조성물 |
| WO2023101418A1 (fr) * | 2021-12-03 | 2023-06-08 | (주)인비보텍 | Composition pour la prévention ou le traitement d'une perte auditive ou d'un acouphène |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314685A (en) * | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
| JPH08511559A (ja) * | 1993-06-18 | 1996-12-03 | スミスクライン・ビーチャム・コーポレイション | 軟外皮ゼラチンに封入された粒子 |
| JP4155593B2 (ja) * | 1994-10-26 | 2008-09-24 | ノバルティス・アクチエンゲゼルシャフト | 医薬組成物 |
| NZ309624A (en) * | 1995-06-06 | 1999-04-29 | Bayer Ag | Non-irritating, non-sensitizing, non-ototoxic (harmful to the ears) antibacterial compositions |
| DZ2479A1 (fr) * | 1997-05-05 | 2003-02-01 | Pfizer | Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. |
| US6440964B1 (en) * | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
| AU2001274858A1 (en) * | 2000-06-08 | 2001-12-17 | Board Of Regents, The University Of Texas System | Heterocycle derivatives and methods of use for treating anthrax infection |
| PL363153A1 (en) * | 2000-06-16 | 2004-11-15 | Hercules Incorporated | Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| US20040033938A1 (en) * | 2000-09-12 | 2004-02-19 | Britten Nancy J. | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| CA2416563A1 (fr) * | 2000-09-12 | 2002-03-21 | Pharmacia & Upjohn Company | Composition pharmaceutique dotee d'une activite aqueuse specifique |
| TW200403072A (en) * | 2002-01-23 | 2004-03-01 | Upjohn Co | Combination therapy for the treatment of bacterial infections |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
-
2004
- 2004-07-19 BR BRPI0412581-9A patent/BRPI0412581A/pt not_active IP Right Cessation
- 2004-07-19 MX MXPA06001288A patent/MXPA06001288A/es not_active Application Discontinuation
- 2004-07-19 AU AU2004258745A patent/AU2004258745A1/en not_active Abandoned
- 2004-07-19 EP EP04744112A patent/EP1651210A1/fr not_active Withdrawn
- 2004-07-19 CN CNA200480022099XA patent/CN1829510A/zh active Pending
- 2004-07-19 WO PCT/IB2004/002461 patent/WO2005009436A1/fr not_active Ceased
- 2004-07-19 RU RU2006101628/14A patent/RU2319508C2/ru not_active IP Right Cessation
- 2004-07-19 JP JP2006521702A patent/JP2007500691A/ja not_active Withdrawn
- 2004-07-19 KR KR1020067002034A patent/KR100780983B1/ko not_active Expired - Fee Related
- 2004-07-19 CA CA002533101A patent/CA2533101A1/fr not_active Abandoned
-
2005
- 2005-12-21 IL IL172735A patent/IL172735A0/en unknown
- 2005-12-29 CO CO05130971A patent/CO5650245A2/es not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600096A patent/ZA200600096B/en unknown
- 2006-02-28 NO NO20060982A patent/NO20060982L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL172735A0 (en) | 2006-04-10 |
| JP2007500691A (ja) | 2007-01-18 |
| ZA200600096B (en) | 2007-02-28 |
| WO2005009436A8 (fr) | 2005-05-06 |
| KR100780983B1 (ko) | 2007-11-30 |
| CA2533101A1 (fr) | 2005-02-03 |
| EP1651210A1 (fr) | 2006-05-03 |
| MXPA06001288A (es) | 2006-04-11 |
| CO5650245A2 (es) | 2006-06-30 |
| CN1829510A (zh) | 2006-09-06 |
| WO2005009436A1 (fr) | 2005-02-03 |
| RU2319508C2 (ru) | 2008-03-20 |
| RU2006101628A (ru) | 2006-08-27 |
| BRPI0412581A (pt) | 2006-09-19 |
| KR20060031873A (ko) | 2006-04-13 |
| AU2004258745A1 (en) | 2005-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060982L (no) | Dispergerende formulering for et anti-inflammatorisk middel | |
| NO20054777L (no) | Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser | |
| Nayak et al. | Experimental evaluation of ethanolic extract of Carapa guianensis L. leaf for its wound healing activity using three wound models | |
| Tandon et al. | Hepatoprotective activity of Vitex negundo leaf extract against anti-tubercular drugs induced hepatotoxicity | |
| NO20054260L (no) | Disepergebar formulering av en anti-inflammatorisk forbindelse | |
| WO2008085484A3 (fr) | Procédé de traitement de l'affection abdominale inflammatoire | |
| AR047067A1 (es) | Metodos para el uso de bifidobacterias probioticas para animales de compania | |
| WO2010070675A8 (fr) | Formulation(s) topique(s) destinée(s) au traitement de l'inflammation, d'affections cutanées, de maladies des muqueuses et autres maladies associées à celles-ci | |
| NO20075660L (no) | Blanding for behandling av inflammatoriske sykdommer | |
| EP4058193A4 (fr) | Cassette sectionnable et cadre d'intégration avec connecteurs, et procédés de préparation d'échantillons de tissu de biopsie | |
| EA200800798A1 (ru) | Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха | |
| NO20100301L (no) | Forbedrete brimonidinsammensetninger for behandling av erytem | |
| NO20070293L (no) | Aryl-substituerte piperazinderivater | |
| NO20056223L (no) | Preparat til behandling av infeksjon hos kveg og svin | |
| AR058679A1 (es) | Preparacion farmaceutica que contiene meloxicam | |
| WO2007112453A3 (fr) | Méthodes et compositions pour traiter des conditions | |
| BRPI0512311A (pt) | uso de meloxicam em medicina veterinária para o tratamento de doenças inflamatórias dolorosas | |
| Reddy et al. | Oral myiasis in children | |
| Bourne et al. | Veterinary issues related to bears (Ursidae) | |
| AR044271A1 (es) | Suplemento dietetico y metodo para el tratamiento y prevencion de ulceras en el tracto digestivo en equinos y otros animales | |
| CN108096226A (zh) | 一种含聚赖氨酸的口腔溃疡贴膜及其制备方法 | |
| Kroigaard et al. | KCa3. 1 channel downregulation and impaired endothelium‐derived hyperpolarization‐type relaxation in pulmonary arteries from chronically hypoxic rats | |
| DE102017113263A1 (de) | Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke | |
| WO2018230931A3 (fr) | Composition pour prévenir et traiter les maladies métaboliques | |
| MD2516C2 (ro) | Remediu medicamentos antiinflamator, antiseptic şi antifungic sub formă de gel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |